DP Biology (last assessment 2024)

Test builder »

Question 22M.1.HL.TZ2.37

Select a Test
Date May 2022 Marks available [Maximum mark: 1] Reference code 22M.1.HL.TZ2.37
Level HL Paper 1 Time zone TZ2
Command term Question number 37 Adapted from N/A
37.
[Maximum mark: 1]
22M.1.HL.TZ2.37

Cetuximab is a type of monoclonal antibody used to treat cancers of the large intestine. How are these monoclonal antibodies obtained?

A. From hybridoma cells produced by fusion of cancer cells

B. From hybridoma cells produced by fusion of tumour cells and plasma cells

C. From plasma cells produced by small mammals in response to antigens from cancer cells

D. From hybridoma cells produced by small mammals in response to antigens from cancer cells

[1]

Markscheme

B

Syllabus sections